Academic literature on the topic 'Self-emulsifying capsule'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Self-emulsifying capsule.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Self-emulsifying capsule"

1

Patel, Vipul P., Hardik A. Lakkad, and Kalpesh Chhotalal Ashara. "Formulation Studies of Solid Self-Emulsifying Drug Delivery System of Ivermectin." Folia Medica 60, no. 4 (2018): 580–93. http://dx.doi.org/10.2478/folmed-2018-0024.

Full text
Abstract:
Abstract Background: The suggested dose of ivermectin is 300 μG/kg/day for onchocerciasis but it has low water solubility and poor oral bioavailability. Aim: To prepare and evaluate a solid lipid-based self-emulsifying drug delivery system of ivermectin. Materials and methods: Based on supersaturated solubility study, oil, surfactant, and co-surfactant were selected. On the basis of ternary phase diagrams and simplex-lattice design, self-emulsifying, drug delivery formulations had been developed and optimized. Ivermectin-excipients compatibility studies were performed using differential scanning calorimetry and Fourier transform infrared spectroscopy. Solid self-emulsifying drug delivery formulation was formulated from the optimized batch by surface assimilation method and filled into hard gelatin capsules. In vitro release rate and in vivo pharmacokinetic parameters of ivermectin from the capsules were determined. Two-tailed paired t-test/Dunnett multiple comparison tests were performed for in vivo pharmacokinetic parameter at 95 % of confidence level. Results: Soybeans oil, tween 80, and span 80 were selected as oil, surfactant, and co-surfactant respectively. The ternary diagrams were shown the maximum area for emulsion in 1:2 surfactant/co-surfactant ratio. The optimized batch had found with 30 mg ivermectin, 6.17 g soybeans oil, 0.30 g tween 80, and 3.50 g span 80. All differential scanning calorimetry and Fourier transform infrared characteristic peaks of the optimized formulation were identical with that of pure ivermectin. The area under the curve of ivermectin from the capsule was about two-fold higher than that of ivermectin suspension. Conclusions: Solid self-emulsifying drug delivery system was an effective oral solid dosage form to improve the oral bioavailability of ivermectin.
APA, Harvard, Vancouver, ISO, and other styles
2

Harsh, Pathak, Pande Sonal, Jiwani Munaf, Ankalge Rajesh, and Rohit Mehul. "Pharmaceutical Aspects of Self Emulsifying Drug Delivery System: A Comprehensive Review." Recent Trends in Pharmaceutical Sciences and Research 2, no. 1 (2019): 19–44. https://doi.org/10.5281/zenodo.3474625.

Full text
Abstract:
<em>Low aqueous solubility of the newly discovered drug possesses a great challenge for the development of dosage form with suitable applicability. Self-Emulsifying Drug Delivery System (SEDDS) provides an excellent alternative for increasing solubility of lipid soluble drugs which is achieved by microemulsion through chemical means. </em><em>Self-Emulsifying drug delivery system is the blend of surfactants and oils which are isotropic in nature. It also includes co-solvents which upon gentle agitation gets emulsified under conditions mimicking to those which would be encountered in the gastrointestinal tract. </em><em>This article discusses mechanism components, pharmaceutical aspects, patents and recent work done on SEDDS.</em>
APA, Harvard, Vancouver, ISO, and other styles
3

Park, Heejun, Eun-Sol Ha, and Min-Soo Kim. "Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems." Pharmaceutics 12, no. 4 (2020): 365. http://dx.doi.org/10.3390/pharmaceutics12040365.

Full text
Abstract:
Self-emulsifying drug delivery systems (SEDDSs) are a vital strategy to enhance the bioavailability (BA) of formulations of poorly water-soluble compounds. However, these formulations have certain limitations, including in vivo drug precipitation, poor in vitro in vivo correlation due to a lack of predictive in vitro tests, issues in handling of liquid formulation, and physico-chemical instability of drug and/or vehicle components. To overcome these limitations, which restrict the potential usage of such systems, the supersaturable SEDDSs (su-SEDDSs) have gained attention based on the fact that the inclusion of precipitation inhibitors (PIs) within SEDDSs helps maintain drug supersaturation after dispersion and digestion in the gastrointestinal tract. This improves the BA of drugs and reduces the variability of exposure. In addition, the formulation of solid su-SEDDSs has helped to overcome disadvantages of liquid or capsule dosage form. This review article discusses, in detail, the current status of su-SEDDSs that overcome the limitations of conventional SEDDSs. It discusses the definition and range of su-SEDDSs, the principle mechanisms underlying precipitation inhibition and enhanced in vivo absorption, drug application cases, biorelevance in vitro digestion models, and the development of liquid su-SEDDSs to solid dosage forms. This review also describes the effects of various physiological factors and the potential interactions between PIs and lipid, lipase or lipid digested products on the in vivo performance of su-SEDDSs. In particular, several considerations relating to the properties of PIs are discussed from various perspectives.
APA, Harvard, Vancouver, ISO, and other styles
4

S.G.Gavande, R.O.Sonwane A.D.Pichkewar S.S.Dorik. "REVIEW ON IMMEDIATE RELEASE DOSAGE FORM." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES o6, no. 04 (2019): 8509–18. https://doi.org/10.5281/zenodo.2652693.

Full text
Abstract:
<em>Most popular immediate release dosage forms such as tablet, capsule and pellet.</em><em> Because of its convenience of self-administration, and simple to the manufacturing. The type of dosage from is some advantages such as improved stability of formulation. Improved bioavablity of Product. Rapid onset action and cost effective as compare to other dosage formulation. They disintegrant are selected as type of dosage and physical characteristics of drugs. </em><em>The basic approach used in development tablets, capsule and pellet as the use of some excipient like superdisintegrants, Bulking agent, Emulsifying agent, Binders, Lubricants, Flavouring and Sweetening agent As a drug entity nears the end of its patent life, it is common for pharmaceutical manufacturers to develop a given drug entity in a latest and improved dosage form.</em> <em>The manufacturing of Immediate release tablet, capsule and pellet they using various method such as, Tablet Modling, Wet Granulation, Direct Compression, Solid Dispersion. capsule Direct filling, wet Granulation, and pellets Extrusion, Sphronization, Globulation, Spray Drying, Spray congealing, Compression.</em> <strong>Key Words</strong>:- <em>Immediate Release, Superdisintigrent, Conventional Techniques.</em>
APA, Harvard, Vancouver, ISO, and other styles
5

Ansari, Khalid Akhter, Kunal Pratap Pagar, Shoeb Anwar, and Pradeep Ratilal Vavia. "Design and optimization of self-microemulsifying drug delivery system (SMEDDS) of felodipine for chronotherapeutic application." Brazilian Journal of Pharmaceutical Sciences 50, no. 1 (2014): 203–12. http://dx.doi.org/10.1590/s1984-82502011000100021.

Full text
Abstract:
The objective of this research work was to design, develop and optimize the self micro-emulsifying drug delivery system (SMEDDS) of Felodipine (FL) filled in hard gelatine capsule coated with polymer in order to achieve rapid drug release after a desired time lag in the management of hypertension. Microemulsion is composed of a FL, Lauroglycol FCC, Transcutol P and Cremophor EL. The optimum surfactant to co-surfactant ratio was found to be 2:1. The resultant microemulsions have a particle size in the range of 65-85 nm and zeta potential value of -13.71 mV. FL release was adequately adjusted by using pH independent polymer i.e. ethyl cellulose along with dibutyl phthalate as plasticizer. Influence of formulation variables like viscosity of polymer, type of plasticizer and percent coating weight gain was investigated to characterize the time lag. The developed formulation of FL SMEDDS capsules coated with ethyl cellulose showed time lag of 5-7 h which is desirable for chronotherapeutic application.
APA, Harvard, Vancouver, ISO, and other styles
6

Wannas, Ali N., and Nidhal K. Maraie. "Preparation and in-vitro evaluation of cilostazol self-emulsifying drug delivery system." Al Mustansiriyah Journal of Pharmaceutical Sciences 20, no. 1 (2020): 13–30. http://dx.doi.org/10.32947/ajps.v20i1.682.

Full text
Abstract:
This work reported a first liquid self-nanoemulsifying drug delivery system (SEDD) of cilostazol using oleic acid as oil phase, tween 80 as surfactant, and transcutol as co-surfactant. Cilostazol is a poor water-soluble phosphodiesterase III inhibitor, which has antiplatelet&#x0D; &#x0D; and vasodilator effect used to relief intermittent claudication symptoms. Cilostazol solubility was determined in various oils, surfactants and co-surfactants and phase diagram was constructed at different oil: surfactant: co-surfactant ratios to determine the existence of nano-emulsion region. The in-vitro dissolution profile showed an optimized cilostazol SEDD formula (LT1) containing oleic acid (10%) as oil, tween 80 (45%) as surfactant, and transcutol (45%) as co-surfactant in comparison with the commercial conventionally Tablets. The LT1 formula was thermodynamically sTable, with a zeta potential of -30.48 mV and droplet size 154 nm. The LT1 capsule showed a superior dissolution profile (100%) when compared to the commercial Tablet (64%) of cilostazol.&#x0D; The objective of the present study is to formulate cilostazol as an oral liquid SEDD with better solubility and drug release to overcome a variable bioavailability of the commercial Tablet in which a high-fat meal increases absorption to approximately 90%.
APA, Harvard, Vancouver, ISO, and other styles
7

Shi, Fang, Jingchun Wu, and Bo Zhao. "Preparation and Investigation of Intelligent Polymeric Nanocapsule for Enhanced Oil Recovery." Materials 12, no. 7 (2019): 1093. http://dx.doi.org/10.3390/ma12071093.

Full text
Abstract:
Micro-/nanomotors colloidal particles have attracted increasing interest as composite surfactants, owing to the combined advantages of both Janus solid surfactants and micro-/nanomotors. Here we put micro-/nanomotors colloidal particles into hollow polymeric micro-encapsulates. An intelligent polymeric nanocapsule was prepared for enhanced oil recovery by the self-assembly method. The particle size range of the polymeric capsule can be controlled between 20 to 1000 nm by adjusting the cross-linking thickness of the capsule’s outer membrane. The average particle size of polymeric capsules prepared in the study was 300 nm. The structure and properties of the Intelligent polymeric nanocapsule was characterized by a wide range of technics such as Fourier transform infrared spectroscopy, scanning electron microscopy by laser diffraction, fluorescence microscopy, pendant drop tensiometer, laser particle size instrument, and interface tension analyzer. It was found that the intelligent polymeric nanocapsule exhibited significant interfacial activity at the oil-water interface. When the Janus particles’ concentration reached saturation concentration, the adsorption of the amphiphilic nanoparticles at the interface was saturated, and the equilibrium surface tension dropped to around 31 mN/m. When the particles’ concentration reached a critical concentration of aggregation, the Gibbs stability criterion was fulfilled. The intelligent polymeric nanocapsule system has a better plugging and enhanced oil recovery capacity. The results obtained provide fundamental insights into the understanding of the assembly behavior and emulsifying properties of the intelligent polymeric nanocapsule, and further demonstrate the future potential of the intelligent polymeric nanocapsule used as colloid surfactants for enhanced oil recovery applications.
APA, Harvard, Vancouver, ISO, and other styles
8

Sin, Gi Hyeong, Sun Ho Hong, Yoon Tae Goo, Hyun Min Jung, Sangkil Lee, and Young Wook Choi. "Soft-capsule formulation of a re-esterified triglyceride omega-3 employing self-emulsifying technology and bioavailability evaluation in healthy volunteers." Heliyon 9, no. 10 (2023): e20376. http://dx.doi.org/10.1016/j.heliyon.2023.e20376.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hasan, Naser M. y., Dhaifallah M. Almalki, Mohammed J. k. Althuwaybi, and Hassan M. Alshehri. "SMEDDS TABLET: COMPATABILITY OF SOLID SMEDDS USING VARIOUS PHARMACEUTICAL TABLET EXCIPIENTS." International Journal of Pharmacy and Pharmaceutical Sciences 8, no. 9 (2016): 246. http://dx.doi.org/10.22159/ijpps.2016v8i9.13409.

Full text
Abstract:
&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;There are many successful products on the market which are the culmination of the self-micro-emulsification lipid technology applications. Despite the importance of lipid-based formulations, these systems have some limitations including; stability, complexity during large scale manufacturing process and limited dosage forms to such as soft gelatin capsule. In order to overcome these limitations, the prospect of converting self-micro-emulsifying drug delivery systems (SMEDDS) into tablet dosage form was investigated in this study.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A self-micro-emulsifying oil formulation representing type III A lipid class composed of glycerox 767HC/croduret 40 ss at ratios of (80/20) was converted into solid SMEDDS using solid carrier adsorption method. Powder blends containing magnesium trisilicate hydrate (MTSH) or magnesium lluminum silicate (MAS) at various oil loading factors were mixed with MCC with and without various binders and compressed into tablets using a fixed loading force of approximately of 5 KN. Hardness profiles of these oil loaded tablets were then analyzed.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Powder compacts which contained MTSH with and without SMEDDS oil had shown relatively better compaction properties than MAS. Adding SMEDDS oil solution to either MTSH or MAS at ratios of 1:9 has relatively reduced tablets hardness by almost 2 or 4 folds, respectively.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Progressive inclusion of increasing amounts of SMEDDS oil solution adsorbed unto the solid carrier has incurred a further reduction in the hardness of SMEDDS tablets. It appears that manufacturing of tablet SMEDDS can only be attainable for highly potent drugs as minimal amounts of oil solution added to the powder blends can adversely affect the mechanical strength of compressed tablet.&lt;/p&gt;
APA, Harvard, Vancouver, ISO, and other styles
10

Akhter, Sadika, and Md Ismail Hossain. "Dissolution enhancement of Capmul PG8 and Cremophor EL based Ibuprofen Self Emulsifying Drug Delivery System (SEDDS) using Response surface methodology." International Current Pharmaceutical Journal 1, no. 6 (2012): 138–50. http://dx.doi.org/10.3329/icpj.v1i6.10535.

Full text
Abstract:
In this study, a solubility enhancing technique, Self-emulsifying drug delivery system (SEDDS), was considered to be developed for Ibuprofen, a poorly soluble drug. Capmul PG 8 was used as a co-solvent. As surfactant, hydrophilic surfactant Cremophor EL was considered. A fixed amount of Ibuprofen was added with fixed amount of excipients. Capmul PG8 showed a good solubilizing capacity which dissolved 300 mg/ml of Ibuprofen. Cremophor EL also showed a good solubilizing capacity which dissolved 300 mg/ml of Ibuprofen. Ibuprofen is a poorly soluble drug which was used as experimental drug and pH 7.2 phosphate buffer was used as dissolution medium. The amount of drug was measured form the absorbance of UV spectrophotometer at 221 nm. A 3-level factorial design was carried out to optimize the formulation using design expert software trial version 8.0.3.1. Capmul PG8 and Cremophor EL were used as independent variables where percent drug release at 5, 15 and 45 minutes. The optimized formula contains 24.10 mg Capmul PG8 and 71.02 mg Cremophor EL which releases 27.78%, 44.6% and 74.24% ibuprofen at the mentioned time interval. The present study shows that the Capmul PG8 and Cremophor EL have effect the release profile of capsule Ibuprofen. It is found that it is possible to increase the release of Ibuprofen by using Capmul PG8 and Cremophor EL. DOI: http://dx.doi.org/10.3329/icpj.v1i6.10535 International Current Pharmaceutical Journal 2012, 1(6): 138-150
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Self-emulsifying capsule"

1

S, Harer Priyanka, and Harer Sunil L. "DEVELOPMENT AND EVALUATION OF A SELF-MICRO EMULSIFYING OMEGA-3 FATTY ACID DRUG DELIVERY SYSTEM USING FLAXSEED OIL." In Futuristic Trends in Pharmacy & Nursing Volume 3 Book 7. Iterative International Publishers, Selfypage Developers Pvt Ltd, 2024. http://dx.doi.org/10.58532/v3bapn7p1ch11.

Full text
Abstract:
Self micro-emulsifying drug delivery system is the mixture of oils, surfactants, and cosurfactants, which are emulsified in aqueous media under conditions of gentle agitation and digestive motility that would be encountered in the gastro-intestinal (GI) tract that leads improve the solubility, bioavailability and biocompatibility. Purpose of this work is to prepare self-microemulsifying drug delivery system (SMEDDS) to enhance the oral bioavailability and stability of linseed oil (Omega-3 fatty acid). Linseed contains very high amount of omega-3 fatty acid (55-60%). Solubility of linseed oil (Omega-3 fatty acid) was determined in various solvents. Based on screening for oil, surfactant and co-surfactant; Linseed oil, Cremophor RH-40 Surfactant, and Imwitor-988 Co-surfactant were selected. Pseudo-ternary phase diagrams were constructed to identify the efficient self-emulsification region and particle size distributions and zeta potential of the resultant microemulsions were evaluated. The release study of Omega-3-fatty acid from the SMEED formulation and marketed capsule formulation were compared, and shown to exhibit significantly higher release. Also GC chromatogram showed the better stability of omega-3-fatty acid in SMEED formation as compared to marketed capsule formulation. Our study demonstrated the potential and alternative formulation for efficient delivery of omega-3-fatty acid that contained in linseed oil
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Self-emulsifying capsule"

1

Patel, Apurva R., Chandraiah Godugu, Wilson R. Heather, Stephen Safe, and Mandip S. Sachdeva. "Abstract 3361: Pharmacokinetic and pharmacodynamic evaluation of novel dual channel spray dried enteric coated self-emulsifying capsules for anti-cancer agents in dogs." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-3361.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!